12周有氧运动干预改善MAFLD组织学终点
该研究纳入活检确诊的MAFLD患者,进行12周有氧运动干预,评估肝脏组织学和心血管代谢指标。运动组58%患者纤维化改善一个分期(P=0.034),67%患者肝细胞气球样变改善一个分期(P=0.020),估计V̇O2max较对照组增加17%(P=0.027)。结论提示12周有氧运动可能改善MAFLD组织学终点。
要点
- 12周有氧运动使58%患者纤维化改善一个分期,67%患者肝细胞气球样变改善一个分期。
- 运动组估计V̇O2max较对照组增加17%,但干预后12周和52周未维持。
- 纤维化和气球样变改善者估计V̇O2max分别增加25%和26%。
核心结论
- 12周有氧运动干预可能改善MAFLD的组织学终点。
- 需要制定策略确保MAFLD患者持续参与有氧运动。
研究设计与样本
- 活检确诊的MAFLD患者参与12周有氧运动干预,完成者24例(运动组16例,对照组8例)。
- 在基线、干预完成时及干预完成后12周和52周评估肝脏组织学、心肺适能(估计V̇O2max)、体力活动、人体测量学和生化标志物。
主要发现
- 运动组58%患者纤维化改善一个分期(P=0.034),67%患者肝细胞气球样变改善一个分期(P=0.020)。
- 运动组脂肪变(P=1.000)、小叶内炎症(P=0.739)和NAFLD活动度评分(P=0.172)无变化。
- 运动组估计V̇O2max较对照组增加17%(P=0.027),但干预后12周和52周未维持该改善水平。
- 纤维化改善者估计V̇O2max增加25%(P=0.020),气球样变改善者增加26%(P=0.010)。
- 观察到体重(P=0.038)、腰围(P=0.015)和脂肪量(P=0.007)下降,但无患者达到7%-10%体重减轻。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lifestyle interventions are the primary treatment for metabolic (dysfunction) associated fatty liver disease (MAFLD). However, the histological and cardiometabolic effects of aerobic exercise in MAFLD remain unclear. AIMS: To assess the effects of a 12-week aerobic exercise intervention on histological and cardiometabolic endpoints in MAFLD. METHODS: Patients with biopsy-confirmed MAFLD participated in a 12-week aerobic exercise intervention. Liver histology, cardiorespiratory fitness (estimated V̇O2max ), physical activity, anthropometry and biochemical markers were assessed at baseline, intervention completion, and 12 and 52 weeks after intervention completion. RESULTS: Twenty-four patients completed the exercise intervention (exercise group n = 16, control group n = 8). In the exercise group, 12 weeks of aerobic exercise reduced fibrosis and hepatocyte ballooning by one stage in 58% (P = 0.034) and 67% (P = 0.020) of patients, with no changes in steatosis (P = 1.000), lobular inflammation (P = 0.739) or NAFLD activity score (P = 0.172). Estimated V̇O2max increased by 17% compared to the control group (P = 0.027) but this level of improvement was not maintained at 12 or 52 weeks after the intervention. Patients with fibrosis and ballooning improvement increased estimated V̇O2max by 25% (P = 0.020) and 26% (P = 0.010), respectively. Anthropometric reductions including body mass (P = 0.038), waist circumference (P = 0.015) and fat mass (P = 0.007) were also observed, but no patient achieved 7%-10% weight loss. CONCLUSION: This study highlights the potential benefits of a 12-week aerobic exercise intervention in improving histological endpoints of MAFLD. The development of strategies to ensure continued engagement in aerobic exercise in MAFLD are needed.
引用
- O'Gorman P, Naimimohasses S, Monaghan A, et al. Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention. Aliment Pharmacol Ther. 2020. PMID: 32717123. doi:10.1111/apt.15989
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。